From big fat cells to high blood pressure: a pathway to obesity-associated hypertension

被引:102
作者
Pausova, Z
机构
[1] Univ Nottingham, Brain & Body Ctr, Nottingham NG7 2RD, England
[2] Univ Montreal, Ctr Hosp, Res Ctr, Montreal, PQ, Canada
关键词
adipocyte size; hypertension; obesity;
D O I
10.1097/01.mnh.0000214775.42103.a5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review The environment created by modern industrialized societies has caused an unprecedented rise in the prevalence of obesity and obesity-related disorders, including hypertension. Mechanisms that underlie the development of hypertension in obese individuals are not very well understood; they are thought to involve activation of the sympathetic nervous system, the renin-angiotensin-aldosterone system, and oxidative stress. Recent findings Recent research suggests that obesity-associated hypertension may be causally related to the accumulation of 'dysfunctional' adipose tissue characterized by the presence of 'large' lipid-laden adipocytes. Summary Excess energy-intake leads to an expansion of adipose tissue, a hallmark of obesity. But morphology of the expanded adipose tissue differs across individuals, including the size of adipocytes. The presence of 'large' rather than 'small' adipocytes is associated with functional and structural abnormalities of adipose tissue. These include increased production of bioactive molecules, such as leptin, angiotensinogen, pro-inflammatory cytokines, and reactive oxygen species; insufficient capacity to accommodate excess energy-intake leading to ectopic fat storage in tissues and in turn insulin resistance and hyperinsulinemia; and augmented macrophage infiltration enhancing the production of pro-inflammatory cytokines and reactive oxygen species. Such a 'dysfunctional' adipose tissue may, in turn, induce activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system and oxidative stress and, hence, promote the development of obesity-associated hypertension.
引用
收藏
页码:173 / 178
页数:6
相关论文
共 55 条
[1]   Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: Peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach [J].
Bays, H ;
Mandarino, L ;
DeFronzo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (02) :463-478
[2]  
BOGACKA I, 2005, J CLIN ENDOCRINOL ME
[3]   THE RESPONSE TO LONG-TERM OVERFEEDING IN IDENTICAL-TWINS [J].
BOUCHARD, C ;
TREMBLAY, A ;
DESPRES, JP ;
NADEAU, A ;
LUPIEN, PJ ;
THERIAULT, G ;
DUSSAULT, J ;
MOORJANI, S ;
PINAULT, S ;
FOURNIER, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (21) :1477-1482
[4]   Role of macrophage tissue infiltration in metabolic diseases [J].
Bouloumié, A ;
Curat, CA ;
Sengenès, C ;
Lolmède, K ;
Miranville, A ;
Busse, R .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2005, 8 (04) :347-354
[5]   Identification of genes determining the diet-induced metabolic syndrome in the rat:: Gene-expression profiling [J].
Bourdon, C ;
Bérubé, J ;
Kren, V ;
Pravenec, M ;
Liu, P ;
Hamet, P ;
Arab, S ;
Pausova, Z .
JOURNAL OF HYPERTENSION, 2004, 22 :S65-S65
[6]   Preadipocyte conversion to macrophage -: Evidence of plasticity [J].
Charrière, G ;
Cousin, B ;
Arnaud, E ;
André, M ;
Bacou, F ;
Pénicaud, L ;
Casteilla, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (11) :9850-9855
[7]   Serum immunoreactive leptin concentrations in normal-weight and obese humans [J].
Considine, RV ;
Sinha, MK ;
Heiman, ML ;
Kriauciunas, A ;
Stephens, TW ;
Nyce, MR ;
Ohannesian, JP ;
Marco, CC ;
McKee, LJ ;
Bauer, TL ;
Caro, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :292-295
[8]   ACE, angiotensinogen and obesity: A potential pathway leading to hypertension [J].
Cooper, R ;
McFarlaneAnderson, N ;
Bennett, FI ;
Wilks, R ;
Puras, A ;
Tewksbury, D ;
Ward, R ;
Forrester, T .
JOURNAL OF HUMAN HYPERTENSION, 1997, 11 (02) :107-111
[9]   The concept of selective leptin resistance - Evidence from agouti yellow obese mice [J].
Correia, MLG ;
Haynes, WG ;
Rahmouni, K ;
Morgan, DA ;
Sivitz, WI ;
Mark, AL .
DIABETES, 2002, 51 (02) :439-442
[10]   Role of corticotrophin-releasing factor in effects of leptin on sympathetic nerve activity and arterial pressure [J].
Correia, MLG ;
Morgan, DA ;
Mitchell, JL ;
Sivitz, WL ;
Mark, AL ;
Haynes, WG .
HYPERTENSION, 2001, 38 (03) :384-388